Literature DB >> 8386440

Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice.

A Aguzzi1, E F Wagner, K O Netzer, K Bothe, I Anhauser, A Rethwilm.   

Abstract

Human foamy virus (HFV) is a retrovirus encoding structural genes and, like human immunodeficiency virus and human T cell leukemia virus I, several ancillary reading frames collectively termed the be1 genes. We have previously shown that HFV transgenic mice develop an encephalopathy with neuronal loss in hippocampus and cerebral cortex. We have now raised and characterized rabbit antisera to various recombinant portions of gag, pol, env, and bel-1, the viral trans-activator. Immunoreactivity for gag and bel-1 was observed in nuclei and processes of hippocampal and cortical neurons before the onset of morphological lesions and correlated with the appearance of HFV mRNA. Astrocyte-derived multinucleated giant cells containing HFV proteins were present in the brain of transgenic mice coexpressing full-length HFV genes but not in mice expressing truncated gag and env, suggesting that these genes contain a fusogenic domain. Expression of full-length structural genes decreased the life expectancy of transgenic mice, implying an adjuvant role for these proteins in HFV-induced brain damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386440      PMCID: PMC1886887     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  An unusual virus in cultures from a human nasopharyngeal carcinoma.

Authors:  B G Achong; P W Mansell; M A Epstein; P Clifford
Journal:  J Natl Cancer Inst       Date:  1971-02       Impact factor: 13.506

2.  Isolation of foamy virus from patients with de Quervain thyroiditis.

Authors:  J Werner; H Gelderblom
Journal:  Lancet       Date:  1979-08-04       Impact factor: 79.321

3.  Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific.

Authors:  P C Loh; F Matsuura; C Mizumoto
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

4.  Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat.

Authors:  B Maurer; E Serfling; V ter Meulen; A Rethwilm
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  The prevalence of naturally occurring antibodies to human syncytial virus in East African populations.

Authors:  H K Muller; G Ball; M A Epstein; B G Achong; G Lenoir; A Levin
Journal:  J Gen Virol       Date:  1980-04       Impact factor: 3.891

Review 6.  Human foamy virus: an underestimated neuropathogen?

Authors:  A Aguzzi; K Bothe; E F Wagner; A Rethwilm; I Horak
Journal:  Brain Pathol       Date:  1992-01       Impact factor: 6.508

7.  Molecular cloning of the genome of human spumaretrovirus.

Authors:  A Rethwilm; G Darai; A Rösen; B Maurer; R M Flügel
Journal:  Gene       Date:  1987       Impact factor: 3.688

8.  Expression of human foamy virus is differentially regulated during development in transgenic mice.

Authors:  A Aguzzi; K Bothe; I Anhauser; I Horak; A Rethwilm; E F Wagner
Journal:  New Biol       Date:  1992-03

9.  Human spumavirus antibodies in sera from African patients.

Authors:  C Mahnke; P Kashaiya; J Rössler; H Bannert; A Levin; W A Blattner; M Dietrich; J Luande; M Löchelt; A E Friedman-Kien
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes.

Authors:  R M Flügel; A Rethwilm; B Maurer; G Darai
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  14 in total

Review 1.  Grafting mouse brains: from neurocarcinogenesis to neurodegeneration.

Authors:  A Aguzzi
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

2.  A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.

Authors:  P A Goepfert; K L Shaw; G D Ritter; M J Mulligan
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  Expression and maturation of human foamy virus Gag precursor polypeptides.

Authors:  M L Giron; S Colas; J Wybier; F Rozain; R Emanoil-Ravier
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus.

Authors:  J A Mikovits; P M Hoffman; A Rethwilm; F W Ruscetti
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

5.  Nuclear localization of foamy virus Gag precursor protein.

Authors:  A W Schliephake; A Rethwilm
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus.

Authors:  K I Pfrepper; M Löchelt; H R Rackwitz; M Schnölzer; H Heid; R M Flügel
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 7.  Inflammation in neurodegenerative diseases.

Authors:  Sandra Amor; Fabiola Puentes; David Baker; Paul van der Valk
Journal:  Immunology       Date:  2010-02       Impact factor: 7.397

Review 8.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

9.  Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.

Authors:  J Konvalinka; M Löchelt; H Zentgraf; R M Flügel; H G Kräusslich
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Functional analysis of human foamy virus accessory reading frames.

Authors:  G Baunach; B Maurer; H Hahn; M Kranz; A Rethwilm
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.